Teppo O. Leino , Ainoleena Turku , Lauri Urvas , Karuna Adhikari , Jouni Oksanen , Yana Steynen , Jari Yli-Kauhaluoma , Henri Xhaard , Jyrki P. Kukkonen , Erik A.A. Wallén
{"title":"Azulene在食欲素/下丘脑分泌素受体激动剂中的联苯模拟物","authors":"Teppo O. Leino , Ainoleena Turku , Lauri Urvas , Karuna Adhikari , Jouni Oksanen , Yana Steynen , Jari Yli-Kauhaluoma , Henri Xhaard , Jyrki P. Kukkonen , Erik A.A. Wallén","doi":"10.1016/j.bmc.2023.117325","DOIUrl":null,"url":null,"abstract":"<div><p>Azulene is a rare ring structure in drugs, and we investigated whether it could be used as a biphenyl mimetic in known orexin receptor agonist <strong>Nag 26</strong>, which is binding to both orexin receptors OX<sub>1</sub> and OX<sub>2</sub> with preference towards OX<sub>2</sub>. The most potent azulene-based compound was identified as an OX<sub>1</sub> orexin receptor agonist (pEC<sub>50</sub> = 5.79 ± 0.07, maximum response = 81 ± 8% (s.e.m. of five independent experiments) of the maximum response to orexin-A in Ca<sup>2</sup><sup>+</sup> elevation assay). However, the azulene ring and the biphenyl scaffold are not identical in their spatial shape and electron distribution, and their derivatives may adopt different binding modes in the binding site.</p></div>","PeriodicalId":255,"journal":{"name":"Bioorganic & Medicinal Chemistry","volume":"88 ","pages":"Article 117325"},"PeriodicalIF":3.3000,"publicationDate":"2023-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Azulene as a biphenyl mimetic in orexin/hypocretin receptor agonists\",\"authors\":\"Teppo O. Leino , Ainoleena Turku , Lauri Urvas , Karuna Adhikari , Jouni Oksanen , Yana Steynen , Jari Yli-Kauhaluoma , Henri Xhaard , Jyrki P. Kukkonen , Erik A.A. Wallén\",\"doi\":\"10.1016/j.bmc.2023.117325\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Azulene is a rare ring structure in drugs, and we investigated whether it could be used as a biphenyl mimetic in known orexin receptor agonist <strong>Nag 26</strong>, which is binding to both orexin receptors OX<sub>1</sub> and OX<sub>2</sub> with preference towards OX<sub>2</sub>. The most potent azulene-based compound was identified as an OX<sub>1</sub> orexin receptor agonist (pEC<sub>50</sub> = 5.79 ± 0.07, maximum response = 81 ± 8% (s.e.m. of five independent experiments) of the maximum response to orexin-A in Ca<sup>2</sup><sup>+</sup> elevation assay). However, the azulene ring and the biphenyl scaffold are not identical in their spatial shape and electron distribution, and their derivatives may adopt different binding modes in the binding site.</p></div>\",\"PeriodicalId\":255,\"journal\":{\"name\":\"Bioorganic & Medicinal Chemistry\",\"volume\":\"88 \",\"pages\":\"Article 117325\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2023-06-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioorganic & Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0968089623001736\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic & Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0968089623001736","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Azulene as a biphenyl mimetic in orexin/hypocretin receptor agonists
Azulene is a rare ring structure in drugs, and we investigated whether it could be used as a biphenyl mimetic in known orexin receptor agonist Nag 26, which is binding to both orexin receptors OX1 and OX2 with preference towards OX2. The most potent azulene-based compound was identified as an OX1 orexin receptor agonist (pEC50 = 5.79 ± 0.07, maximum response = 81 ± 8% (s.e.m. of five independent experiments) of the maximum response to orexin-A in Ca2+ elevation assay). However, the azulene ring and the biphenyl scaffold are not identical in their spatial shape and electron distribution, and their derivatives may adopt different binding modes in the binding site.
期刊介绍:
Bioorganic & Medicinal Chemistry provides an international forum for the publication of full original research papers and critical reviews on molecular interactions in key biological targets such as receptors, channels, enzymes, nucleotides, lipids and saccharides.
The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. A special feature will be that colour illustrations will be reproduced at no charge to the author, provided that the Editor agrees that colour is essential to the information content of the illustration in question.